Overview Technical Risk & rank Results Accounts Filings Guidance & governance
Guidance tracker
What RUBICON guided, and what came next
| Filed | What the filing says | Next results: profit YoY | Revenue | Move on the day |
|---|---|---|---|---|
| 12 Nov 2026 | Rubicon Research Limited filed the transcript of its Q2 FY2026-27 earnings conference call held on November 5, 2026. Management (CEO Parag Sancheti) said Q2 revenue from operations was INR576 crores versus INR412 crores a year earlier, and PAT was INR90 crores versus INR54 crores; operating EBITDA was INR144 crores... NSE copy | No results filed since | ||
| 19 Aug 2026 | Rubicon Research filed the transcript of its Q1 FY27 earnings conference call held on August 14, 2026. Management reported Q1 revenue from operations of INR534 crores (up 51% year-on-year), EBITDA of INR131 crores (up 65%) and PAT of about INR85 crores (up more than 95%), with PAT including a one-off insurance... NSE copy | +68.0 % | +39.9 % | -4.7 % |
| 02 Jun 2026 | Rubicon Research filed the transcript of its Q4 FY26 earnings call held on May 29, 2026. Management reported Q4 FY26 revenue of INR 5,140 million (up 44% year-on-year), operating EBITDA of INR 1,190 million (up 64%) and PAT of INR 768 million (up 112%); full-year revenue was INR 17,540 million (up 37%) and PAT was... NSE copy | +95.8 % | +51.6 % | +11.1 % |
| 06 Feb 2026 | Rubicon Research filed the transcript of its Q3 FY2025-26 earnings conference call held on February 3, 2026. Management reported Q3 revenue from operations of INR 476 crores (up 52% YoY), EBITDA of INR 112 crores (up 59%), PAT of INR 73 crores (up 91%) and EPS of INR 4.41. CFO Nitin Jajodia said 9M revenue was INR... NSE copy | - | - | +16.5 % |
| 18 Nov 2025 | Rubicon Research filed the transcript of its Q2 FY 2025-26 earnings conference call held on 13 November 2025. Management said revenue grew 39% year-on-year, operating EBITDA grew 53%, and PAT was 56% higher than the previous year, with annualized ROACE of 36% for the quarter (CEO Parag Sancheti). CFO Nitin Jajodia... NSE copy | - | - | +7.2 % |
| 13 Nov 2025 | Rubicon Research Limited filed its Investor Presentation dated 13 November 2025 for the quarter and half year ended 30 September 2025 (Q2 FY26). Q2 FY26 operating revenue was ₹4,120 millions, up 39.2% YoY from ₹2,960 millions; operating EBITDA was ₹943 millions (up 52.9% from ₹617 millions); PAT was ₹539 millions... NSE copy | - | - | +7.2 % |
Filings tagged as guidance, newest first (6 in all), with the company's next results after each: profit and revenue against the same quarter a year before, and the share's move on the results day. Whether the guidance was met is for the reader to judge from both; the site does not score it. The summaries are written by an AI model from the filing and can be wrong - the filing is the source.
Governance
Management, auditors, ratings and legal matters
| Filed | Kind | What the filing says |
|---|---|---|
| 12 Nov 2026 | Legal or regulatory | Rubicon Research Limited filed the transcript of its Q2 FY2026-27 earnings conference call held on November 5, 2026. Management (CEO Parag Sancheti) said Q2 revenue from operations was INR576 crores versus INR412 crores a year earlier, and PAT was INR90 crores versus INR54 crores; operating EBITDA was INR144 crores... NSE copy |
| 19 Aug 2026 | Legal or regulatory | Rubicon Research filed the transcript of its Q1 FY27 earnings conference call held on August 14, 2026. Management reported Q1 revenue from operations of INR534 crores (up 51% year-on-year), EBITDA of INR131 crores (up 65%) and PAT of about INR85 crores (up more than 95%), with PAT including a one-off insurance... NSE copy |
| 20 Jul 2026 | Legal or regulatory | Board of Rubicon Research Limited, at its meeting held July 20, 2026, fixed the 27th AGM for Wednesday, August 26, 2026, through video conferencing or other audio-visual means. The Board fixed Friday, August 7, 2026 as the record date for final dividend of ₹1.50 per equity share (face value ₹1 each) for FY 2025-26,... NSE copy |
| 03 Feb 2026 | Legal or regulatory, Management change | Rubicon Research Limited filed the outcome of its board meeting held on February 3, 2026 (meeting ran from 3:00 PM to 4:30 PM IST). The board approved the appointment of Dr. Pradnya Saravade as Additional Independent Woman Director for three years, from February 3, 2026 to February 2, 2029, subject to shareholder... NSE copy |
| 03 Feb 2026 | Legal or regulatory | Rubicon Research Limited's board approved the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025, at a meeting held February 3, 2026 (3:00 PM to 4:30 PM IST). The filing encloses the results and the statutory auditor's limited review report, which states... NSE copy |
Filings with a management change, a legal or regulatory matter or a credit rating (by their tags), or naming an auditor, a resignation or a pledge of shares; newest first (5 in all). A list of what was filed, not a judgement of the company.